3-O-sulfated heparan sulfate recognized by the antibody HS4C3 contribute to the differentiation of mouse embryonic stem cells via fas signaling

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Hirano, Kazumi ^a   Sasaki, Norihiko ^a   Ichimiya, Tomomi ^a   Miura, Taichi ^a   van Kuppevelt, Toin H ^b   Nishihara, Shoko ^a  

^a SOKA UNIVERSITY   (Japan)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3 O SULFATED HEPARAN SULFATE; ANTIBODY; CASPASE 3; EPITOPE; FAS ANTIGEN; HEPARAN SULFATE; HEPARAN SULFATE 3 O SULFOTRANSFERASE; HEPARIN; HS4C3 PROTEIN; SULFOTRANSFERASE; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG;

3OST GENE; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL SURFACE; CONTROLLED STUDY; CYTOPLASM; EMBRYOID BODY; EMBRYONIC STEM CELL; ENZYME ACTIVATION; GENE; GENE OVEREXPRESSION; GENE SILENCING; GERM LAYER; LIPID RAFT; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; SERUM; SIGNAL TRANSDUCTION; SYNTHESIS; UPREGULATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; EMBRYONIC STEM CELLS; HEPARITIN SULFATE; IMMUNOBLOTTING; MICE; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84865087900     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043440     Document Type: Article

References (43)

1. Esko JD, Selleck SB, (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71: 435-471.
2. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, et al. (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729-777.
3. Lin X, (2004) Functions of heparan sulfate proteoglycans in cell signaling during development. Development 131: 6009-6021.
4. Evans MJ, Kaufman MH, (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156.
5. Martin GR, (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78: 7634-7638.
6. Keller G, (2005) Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 19: 1129-1155.
7. Chambers I, Smith A, (2004) Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 23: 7150-7160.
8. Boiani M, Scholer HR, (2005) Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 6: 872-884.
9. Smith AG, Heath JK, Donaldson DD, Wong GG, Moreau J, et al. (1988) Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336: 688-690.
10. Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, et al. (1988) Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336: 684-687.
11. Niwa H, Burdon T, Chambers I, Smith A, (1998) Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 12: 2048-2060.
12. Niwa H, (2007) How is pluripotency determined and maintained? Development 134: 635-646.
13. Chambers I, Colby D, Robertson M, Nichols J, Lee S, et al. (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655.
14. Ying QL, Nichols J, Chambers I, Smith A, (2003) BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115: 281-292.
15. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH, (2004) Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10: 55-63.
16. Sasaki N, Okishio K, Ui-Tei K, Saigo K, Kinoshita-Toyoda A, et al. (2008) Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. J Biol Chem 283: 3594-3606.
17. Miyabayashi T, Teo JL, Yamamoto M, McMillan M, Nguyen C, et al. (2007) Wnt/β-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc Natl Acad Sci U S A 104: 5668-5673.
18. Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, et al. (2007) FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 134: 2895-2902.
19. Sasaki N, Hirano T, Ichimiya T, Wakao M, Hirano K, et al. (2009) The 3′-phosphoadenosine 5′-phosphosulfate transporters, PAPST1 and 2, contribute to the maintenance and differentiation of mouse embryonic stem cells. PLoS One 4: e8262.
20. Kraushaar DC, Yamaguchi Y, Wang L, (2010) Heparan sulfate is required for embryonic stem cells to exit from self-renewal. J Biol Chem 285: 5907-5916.
21. Lanner F, Lee KL, Sohl M, Holmborn K, Yang H, et al. (2010) Heparan sulfation-dependent fibroblast growth factor signaling maintains embryonic stem cells primed for differentiation in a heterogeneous state. Stem Cells 28: 191-200.
22. Johnson CE, Crawford BE, Stavridis M, Ten Dam G, Wat AL, et al. (2007) Essential alterations of heparan sulfate during the differentiation of embryonic stem cells to Sox1-enhanced green fluorescent protein-expressing neural progenitor cells. Stem Cells 25: 1913-1923.
23. Baldwin RJ, ten Dam GB, van Kuppevelt TH, Lacaud G, Gallagher JT, et al. (2008) A developmentally regulated heparan sulfate epitope defines a subpopulation with increased blood potential during mesodermal differentiation. Stem Cells 26: 3108-3118.
24. Ten Dam GB, Kurup S, van de Westerlo EM, Versteeg EM, Lindahl U, et al. (2006) 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J Biol Chem 281: 4654-4662.
25. Mochizuki H, Yoshida K, Shibata Y, Kimata K, (2008) Tetrasulfated disaccharide unit in heparan sulfate: enzymatic formation and tissue distribution. J Biol Chem 283: 31237-31245.
26. Xia G, Chen J, Tiwari V, Ju W, Li JP, et al. (2002) Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. J Biol Chem 277: 37912-37919.
27. Kamiyama S, Sasaki N, Goda E, Ui-Tei K, Saigo K, et al. (2006) Molecular cloning and characterization of a novel 3′-phosphoadenosine 5′-phosphosulfate transporter, PAPST2. J Biol Chem 281: 10945-10953.
28. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC, (1993) Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A 90: 8424-8428.
29. Smith AG, Hooper ML, (1987) Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev Biol 121: 1-9.
30. Smits NC, Lensen JF, Wijnhoven TJ, Ten Dam GB, Jenniskens GJ, et al. (2006) Phage display-derived human antibodies against specific glycosaminoglycan epitopes. Methods Enzymol 416: 61-87.
31. van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH, (1998) Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem 273: 12960-12966.
32. Bennett M, Macdonald K, Chan SW, Luzio JP, Simari R, et al. (1998) Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 282: 290-293.
33. Ko YG, Lee JS, Kang YS, Ahn JH, Seo JS, (1999) TNF-alpha-mediated apoptosis is initiated in caveolae-like domains. J Immunol 162: 7217-7223.
34. Legembre P, Moreau P, Daburon S, Moreau JF, Taupin JL, (2002) Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas. Cell Death Differ 9: 329-339.
35. Schuck S, Honsho M, Ekroos K, Shevchenko A, Simons K, (2003) Resistance of cell membranes to different detergents. Proc Natl Acad Sci U S A 100: 5795-5800.
36. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, et al. (2002) Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418: 417-422.
37. Duval D, Malaise M, Reinhardt B, Kedinger C, Boeuf H, (2004) A p38 inhibitor allows to dissociate differentiation and apoptotic processes triggered upon LIF withdrawal in mouse embryonic stem cells. Cell Death Differ 11: 331-341.
38. Fujita J, Crane AM, Souza MK, Dejosez M, Kyba M, et al. (2008) Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2: 595-601.
39. Gajate C, Del Canto-Janez E, Acuna AU, Amat-Guerri F, Geijo E, et al. (2004) Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis. J Exp Med 200: 353-365.
40. Schutze S, Tchikov V, Schneider-Brachert W, (2008) Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat Rev Mol Cell Biol 9: 655-662.
41. Ivanov VN, Lopez Bergami P, Maulit G, Sato TA, Sassoon D, et al. (2003) FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface. Mol Cell Biol 23: 3623-3635.
42. Villena J, Mainez J, Noguer O, Contreras H, Granes F, et al. (2006) Syndecan-2 expression increases serum-withdrawal-induced apoptosis, mediated by re-distribution of Fas into lipid rafts, in stably transfected Swiss 3T3 cells. Apoptosis 11: 2065-2075.
43. Brunlid G, Pruszak J, Holmes B, Isacson O, Sonntag KC, (2007) Immature and neurally differentiated mouse embryonic stem cells do not express a functional Fas/Fas ligand system. Stem Cells 25: 2551-2558.